BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:01 PM
 | 
May 19, 2009
 |  BC Extra  |  Company News

FDA panel votes against Debiopharm's Sanvar

An FDA advisory committee voted unanimously on Tuesday that Debiopharm S.A. (Lausanne, Switzerland) has not demonstrated that the potential benefits outweigh the potential risks of Sanvar vapreotide as an...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >